We worked with San Francisco-based Syapse to engage Korea’s top 10 oncology hospitals and generate interest in its precision medicine system, which helps oncology clinicians analyse real-time patient data and tailor treatment plans. 

As a result, Syapse signed an MOU to collaborate with Ajou University Hospital. The two parties will create a data sharing network, undertake R&D and develop a precision medicine platform to help provide the hospital’s patients with customised diagnosis and world-class cancer care.

Mission Bio is a Silicon Valley-based company that has developed an instrument for cell separation and labelling for sequencing. 

The company asked us to identify prospective distribution and service partners across Japan, Korea and China to help it ramp up sales in the region. We first assessed a long-list of potential partners in genomics, oncology and life science R&D. We then met and qualified these companies and recommended a short-list of the best candidates. 

We organised an Asia visit for Mission Bio to meet the management of our recommended partners and supported discussions and initial negotiations. Following the Asia visit, Mission Bio appointed partners from the recommended shortlists in each country.

German life sciences firm biotechrabbit appointed us to drive its expansion in China. 

We engaged 79 Chinese companies — including IVD manufacturers, life science distributors and diagnostic service providers - to qualify potential distributors and industrial customers.

After a roadshow with biotechrabbit’s CEO to meet the 20 most promising candidates, we finalised a market and channel strategy, helped appoint distributors for northern, central and southern China and have continued to manage our client’s partners and win sales for the firm.